Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shukra Pharmaceuticals has informed that the company has entered into distributorship arrangements with leading surgical and medical instrument manufacturers for exclusive/non-exclusive distribution of their products in the region of India. Details of the arrangement are enclosed.
The above information is a part of company’s filings submitted to BSE.